Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Concord Medical to Report First Half 2017 Financial Results on August 25, 2017 2017-08-11 16:00
Vista Launches VTO, Providing High-end Health Care Services To High Net-worth Individuals In China 2017-08-11 15:09
CARsgen Launches First-in-Class Anti-Claudin18.2 CAR-T Clinical Trial 2017-08-10 14:10
Korea Institute of Science and Technology (KIST) Develops a New Drug for Alzheimer's Disease 2017-08-09 21:00
CPHI to Hold Second Quarter 2017 Earnings Conference Call On Tuesday August 15, 2017 at 8:30 a.m. ET 2017-08-08 18:00
Australian Medical Technology Company LBT Innovations WoundVue(TM) Prototype to be Used at Central Adelaide Health Network 2017-08-08 18:00
VolitionRx Limited Schedules Second Quarter 2017 Earnings Conference Call and Business Update 2017-08-04 04:30
China Biologic Reports Financial Results for the Second Quarter of 2017 2017-08-03 05:00
First Human Subject Enrolled in Lumosa Therapeutics' Phase 1 Trial for LT3001, a New Drug Molecule for Acute Ischemic Stroke 2017-08-01 09:46
WuXi's Pharmaceutical Development Services Division Merges with STA 2017-07-31 08:00
HeadaTerm (TM): The Cost Would Not Add Pain to Migraine Patients 2017-07-28 21:00
Frontier Biotech licenses 3BNC117, a novel broad-spectrum HIV neutralizing antibody 2017-07-25 19:50
Concord Medical Announces Changes to the Board 2017-07-24 18:36
STA Signs Supply Agreement with TESARO 2017-07-24 08:00
VolitionRx Limited to host a conference call regarding a 13,500 Subject Colorectal Cancer Screening Trial with the Early Detection Research Network of the U.S. National Cancer Institute 2017-07-20 04:30
China Biologic Products to Report Second Quarter of 2017 Financial Results 2017-07-19 20:00
Mr. Stephen Ooi, Former Zimmer Executive, Newly Appointed as Independent Board Director of XinRong Medical 2017-07-19 19:17
Volition America, Inc. Announces a Colorectal Cancer Screening Trial containing approximately 13,500 Subjects in Collaboration with the Early Detection Research Network of the U.S. National Cancer Institute 2017-07-18 18:30
China's First Fully Human, Full-length Anti-PD-L1 Monoclonal Antibody Receives Approval to Initiate Clinical Trials by the China Food and Drug Administration 2017-07-17 20:50
ShangPharma Innovation and the University of California San Francisco Announce Strategic Research Collaboration 2017-07-13 23:00
1 237 238 239 240 241 421